The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Functional Dysregulation of CDC42 Causes Diverse Developmental Phenotypes
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is consonant with other activating Switch II mutations in the RAC family, RAC2[Q61L], 30 RAC2[D63V], 22 and CDC42 [Y64C], 23 which impair GDP exchange and GTP hydrolysis.”
From Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects (2019) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
GeneMatcher: a matching tool for connecting investigators with an interest in the same gene.
Sobreira, N., Schiettecatte, F., Valle, D., & Hamosh, A. (2015) · Human Mutation · doi:10.1002/humu.22844 · Cited by 1,529
The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities
Chong, J. X., Buckingham, K. J., Jhangiani, S. N., Boehm, C., Sobreira, N., Smith, J. D., Harrell, T. M., McMillin, M. J., Wiszniewski, W., Gambin, T., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.06.009 · Cited by 643
Self-citationGenomic and Biological Characterization of Exon 4 KRAS Mutations in Human Cancer
Janakiraman, M., Vakiani, E., Zeng, Z., Pratilas, C. A., Taylor, B. S., Chitale, D., Halilovic, E., Wilson, M., Huberman, K., Ricarte Filho, J. C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0192 · Cited by 290
Gremer, L., Merbitz-Zahradnik, T., Dvorsky, R., Cirstea, I. C., Kratz, C. P., Zenker, M., Wittinghofer, A., & Ahmadian, M. R. (2011) · Human Mutation · doi:10.1002/humu.21377 · Cited by 158
Self-citation
Research works printed but not linked: 49
- Bamshad, 2011, Exome sequencing as a tool for Mendelian disease gene discovery, Nat. Rev. Genet., 12, 745, 10.1038/nrg3031 · DOI
- Menke, 2016, CREBBP mutations in individuals without Rubinstein-Taybi syndrome phenotype, Am. J. Med. Genet. A., 170, 2681, 10.1002/ajmg.a.37800 · DOI
- Lee, 2017, Mutations in fibronectin cause a subtype of spondylometaphyseal dysplasia with “corner fractures”, Am. J. Hum. Genet., 101, 815, 10.1016/j.ajhg.2017.09.019 · DOI
- Niceta, 2015, Mutations impairing GSK3-mediated MAF phosphorylation cause cataract, deafness, intellectual disability, seizures, and a Down syndrome-like facies, Am. J. Hum. Genet., 96, 816, 10.1016/j.ajhg.2015.03.001 · DOI
- Reijnders, 2017, RAC1 missense mutations in developmental disorders with diverse phenotypes, Am. J. Hum. Genet., 101, 466, 10.1016/j.ajhg.2017.08.007 · DOI · Paper page
- Martinelli, 2008, Diverse driving forces underlie the invariant occurrence of the T42A, E139D, I282V and T468M SHP2 amino acid substitutions causing Noonan and LEOPARD syndromes, Hum. Mol. Genet., 17, 2018, 10.1093/hmg/ddn099 · DOI
- Philippakis, 2015, The Matchmaker Exchange: a platform for rare disease gene discovery, Hum. Mutat., 36, 915, 10.1002/humu.22858 · DOI
- Chong, 2016, Gene discovery for Mendelian conditions via social networking: de novo variants in KDM1A cause developmental delay and distinctive facial features, Genet. Med., 18, 788, 10.1038/gim.2015.161 · DOI
- Homsy, 2015, De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies, Science, 350, 1262, 10.1126/science.aac9396 · DOI
- Tanaka, 2015, Mutations in SPATA5 are associated with microcephaly, intellectual disability, seizures, and hearing loss, Am. J. Hum. Genet., 97, 457, 10.1016/j.ajhg.2015.07.014 · DOI
- Farwell Hagman, 2017, Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases, Genet. Med., 19, 224, 10.1038/gim.2016.95 · DOI · Paper page
- Roberts, 2013, Noonan syndrome, Lancet, 381, 333, 10.1016/S0140-6736(12)61023-X · DOI
- Tartaglia, 2010, Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms, Ann. N Y Acad. Sci., 1214, 99, 10.1111/j.1749-6632.2010.05790.x · DOI
- Kircher, 2014, A general framework for estimating the relative pathogenicity of human genetic variants, Nat. Genet., 46, 310, 10.1038/ng.2892 · DOI · Paper page
- Dong, 2015, Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies, Hum. Mol. Genet., 24, 2125, 10.1093/hmg/ddu733 · DOI
- Ioannidis, 2016, REVEL: an ensemble method for predicting the pathogenicity of rare missense variants, Am. J. Hum. Genet., 99, 877, 10.1016/j.ajhg.2016.08.016 · DOI · Paper page
- Takenouchi, 2015, Macrothrombocytopenia and developmental delay with a de novo CDC42 mutation: Yet another locus for thrombocytopenia and developmental delay, Am. J. Med. Genet. A., 167A, 2822, 10.1002/ajmg.a.37275 · DOI
- Takenouchi, 2016, Further evidence of a mutation in CDC42 as a cause of a recognizable syndromic form of thrombocytopenia, Am. J. Med. Genet. A., 170A, 852, 10.1002/ajmg.a.37526 · DOI
- Etienne-Manneville, 2004, Cdc42--the centre of polarity, J. Cell Sci., 117, 1291, 10.1242/jcs.01115 · DOI
- Heasman, 2008, Mammalian Rho GTPases: new insights into their functions from in vivo studies, Nat. Rev. Mol. Cell Biol., 9, 690, 10.1038/nrm2476 · DOI · Paper page
- Colicelli, 2004, Human RAS superfamily proteins and related GTPases, Sci. STKE, 2004, RE13, 10.1126/stke.2502004re13 · DOI · Paper page
- Dvorsky, 2004, Always look on the bright site of Rho: structural implications for a conserved intermolecular interface, EMBO Rep., 5, 1130, 10.1038/sj.embor.7400293 · DOI
- Chang, 2016, Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity, Nat. Biotechnol., 34, 155, 10.1038/nbt.3391 · DOI · Paper page
- Pirone, 2001, Evolutionary expansion of CRIB-containing Cdc42 effector proteins, Trends Genet., 17, 370, 10.1016/S0168-9525(01)02311-3 · DOI
- Abdul-Manan, 1999, Structure of Cdc42 in complex with the GTPase-binding domain of the ‘Wiskott-Aldrich syndrome’ protein, Nature, 399, 379, 10.1038/20726 · DOI
- Hemsath, 2005, An electrostatic steering mechanism of Cdc42 recognition by Wiskott-Aldrich syndrome proteins, Mol. Cell, 20, 313, 10.1016/j.molcel.2005.08.036 · DOI
- Morreale, 2000, Structure of Cdc42 bound to the GTPase binding domain of PAK, Nat. Struct. Biol., 7, 384, 10.1038/75158 · DOI
- Gizachew, 2000, Structure of the complex of Cdc42Hs with a peptide derived from P-21 activated kinase, Biochemistry, 39, 3963, 10.1021/bi992646d · DOI
- Hemsath, 2005, Fluorescence approaches for monitoring interactions of Rho GTPases with nucleotides, regulators, and effectors, Methods, 37, 173, 10.1016/j.ymeth.2005.05.014 · DOI
- Kühn, 2015, The structure of FMNL2-Cdc42 yields insights into the mechanism of lamellipodia and filopodia formation, Nat. Commun., 6, 7088, 10.1038/ncomms8088 · DOI
- Melendez, 2013, Cdc42 coordinates proliferation, polarity, migration, and differentiation of small intestinal epithelial cells in mice, Gastroenterology, 145, 808, 10.1053/j.gastro.2013.06.021 · DOI
- Zegers, 2014, Rho GTPases in collective cell migration, Small GTPases, 5, e28997, 10.4161/sgtp.28997 · DOI
- Beaty, 2014, Digging a little deeper: the stages of invadopodium formation and maturation, Eur. J. Cell Biol., 93, 438, 10.1016/j.ejcb.2014.07.003 · DOI
- Welchman, 2007, Similar requirements for CDC-42 and the PAR-3/PAR-6/PKC-3 complex in diverse cell types, Dev. Biol., 305, 347, 10.1016/j.ydbio.2007.02.022 · DOI
- Lohmer, 2016, A sensitized screen for genes promoting invadopodia function in vivo: CDC-42 and Rab GDI-1 direct distinct aspects of invadopodia formation, PLoS Genet., 12, e1005786, 10.1371/journal.pgen.1005786 · DOI
- Choi, 2010, sel-11 and cdc-42, two negative modulators of LIN-12/Notch activity in C. elegans, PLoS ONE, 5, e11885, 10.1371/journal.pone.0011885 · DOI
- Schmid, 2015, Signal transduction during C. elegans vulval development: a NeverEnding story, Curr. Opin. Genet. Dev., 32, 1, 10.1016/j.gde.2015.01.006 · DOI
- Mello, 1991, Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences, EMBO J., 10, 3959, 10.1002/j.1460-2075.1991.tb04966.x · DOI
- Cordeddu, 2009, Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair, Nat. Genet., 41, 1022, 10.1038/ng.425 · DOI
- Flex, 2014, Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis, Hum. Mol. Genet., 23, 4315, 10.1093/hmg/ddu148 · DOI
- Gripp, 2010, High incidence of progressive postnatal cerebellar enlargement in Costello syndrome: brain overgrowth associated with HRAS mutations as the likely cause of structural brain and spinal cord abnormalities, Am. J. Med. Genet. A., 152A, 1161, 10.1002/ajmg.a.33391 · DOI
- Nobes, 1995, Rho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility, Biochem. Soc. Trans., 23, 456, 10.1042/bst0230456 · DOI
- Arias-Romero, 2013, Targeting Cdc42 in cancer, Expert Opin. Ther. Targets, 17, 1263, 10.1517/14728222.2013.828037 · DOI
- Pedersen, 2012, Rho GTPase function in development: how in vivo models change our view, Exp. Cell Res., 318, 1779, 10.1016/j.yexcr.2012.05.004 · DOI
- Aoki, 2013, Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome, Am. J. Hum. Genet., 93, 173, 10.1016/j.ajhg.2013.05.021 · DOI
- Yamamoto, 2015, Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome, J. Med. Genet., 52, 413, 10.1136/jmedgenet-2015-103018 · DOI
- Sini, 2004, Abl-dependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation, Nat. Cell Biol., 6, 268, 10.1038/ncb1096 · DOI · Paper page
- Holly, 2005, The unique N-terminus of R-ras is required for Rac activation and precise regulation of cell migration, Mol. Biol. Cell, 16, 2458, 10.1091/mbc.e03-12-0917 · DOI
- Kaduwal, 2015, Sur8/Shoc2 promotes cell motility and metastasis through activation of Ras-PI3K signaling, Oncotarget, 6, 33091, 10.18632/oncotarget.5173 · DOI
Cited by
Common genetic variants contribute to risk of rare severe neurodevelopmental disorders
Niemi, M. E. K., Martin, H. C., Rice, D. L., Gallone, G., Gordon, S., Kelemen, M., McAloney, K., McRae, J., Radford, E. J., Yu, S., et al. (2018) · Nature · doi:10.1038/s41586-018-0566-4 · Cited by 340
RHO GTPases: from new partners to complex immune syndromes
El Masri, R., & Delon, J. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00500-7 · Cited by 131
Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects
Hsu, A. P., Donkó, A., Arrington, M. E., Swamydas, M., Fink, D., Das, A., Escobedo, O., Bonagura, V., Szabolcs, P., Steinberg, H. N., et al. (2019) · Blood · doi:10.1182/blood-2018-11-886028 · Cited by 92
Somatic mutations alter the differentiation outcomes of iPSC-derived neurons
Puigdevall, P., Jerber, J., Danecek, P., Castellano, S., & Kilpinen, H. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100280 · Cited by 29
Metadata
- Authors
- Martinelli, S., Krumbach, O. H. F., Pantaleoni, F., Coppola, S., Amin, E., Pannone, L., Nouri, K., Farina, L., Dvorsky, R., Lepri, F., Buchholzer, M., Konopatzki, R., Walsh, L., Payne, K., Pierpont, M. E., Vergano, S. S., Langley, K. G., Larsen, D., Farwell, K. D., Tang, S., Mroske, C., Gallotta, I., Di Schiavi, E., della Monica, M., Lugli, L., Rossi, C., Seri, M., Cocchi, G., Henderson, L., Baskin, B., Alders, M., Mendoza-Londono, R., Dupuis, L., Nickerson, D. A., Chong, J. X., Meeks, N., Brown, K., Causey, T., Cho, M. T., Demuth, S., Digilio, M. C., Gelb, B. D., Bamshad, M. J., Zenker, M., Ahmadian, M. R., Hennekam, R. C., Tartaglia, M., & Mirzaa, G. M.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 102
- Issue
- 2
- Pages
- 309-320
- ISSN
- 0002-9297
- Cited by
- 188
- References
- 5
- Language
- en
- Licence
- Funders
- National Human Genome Research Institute
- National Institute of Neurological Disorders and Stroke (K08NS092898)
- University of Washington
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Heart, Lung, and Blood Institute (HG006493, U01HL131003, UM1HL098123, UM1HL098147, UM1HL098162, UM1HL128711, UM1HL128761)
- Heinrich-Heine-Universität Düsseldorf (9772617)
- Associazione Italiana per la Ricerca sul Cancro (IG17583)
- Fondazione Bambino Gesù
- National Institutes of Health (P40 OD010440)
- Center for Mendelian Genomics, University of Washington
- Ministero della Salute (RF-2011-02349938)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Functional Dysregulation of CDC42 Causes Diverse Developmental Phenotypes. https://app.cochat.ai/papers/10.1016/j.ajhg.2017.12.015
- The paper
- Martinelli, S., Krumbach, O. H. F., Pantaleoni, F., Coppola, S., Amin, E., Pannone, L., Nouri, K., Farina, L., Dvorsky, R., Lepri, F., Buchholzer, M., Konopatzki, R., Walsh, L., Payne, K., Pierpont, M. E., Vergano, S. S., Langley, K. G., Larsen, D., Farwell, K. D., . . . Mirzaa, G. M. (2018). Functional Dysregulation of CDC42 Causes Diverse Developmental Phenotypes. The American Journal of Human Genetics. https://doi.org/10.1016/j.ajhg.2017.12.015